Anti-cancer drug design.

Anti-cancer drug design. Anticancer Drug Des

Saved in:
Bibliographic Details
Corporate Author: Cancer Research Campaign (Great Britain)
Language:Inglés
ISSN:0266-9536
Published: Houndsmills, Basingstoke, Hampshire : Macmillan, c1985-
Oxford : Oxford University Press
Subjects:
Online Access:http://www.ingentaconnect.com/content/cog/antcan
Related Items:Absorbed by: Oncology research
LEADER 01774cas a2200481 a 4500
001 8603523
003 DNLM
005 20130509061527.0
007 cr|cnu||||||||
008 860306d19852001nyubx p 0 0eng
010 |a sn 86017056  
022 |a 0266-9536  |l 0266-9536 
030 |a ACDDEA 
035 |a (DNLM)SR0054270(s) 
035 |a (OCoLC)12929721 
040 |a DNLM  |c DNLM 
060 0 0 |a W1  |b AN859H 
210 1 0 |a Anticancer Drug Des  |2 DNLM 
222 0 |a Anti-cancer drug design 
245 0 0 |a Anti-cancer drug design. 
260 |a Houndsmills, Basingstoke, Hampshire :  |b Macmillan,  |c c1985- 
260 3 |3 -2001:  |a Oxford :  |b Oxford University Press 
300 |a v. :  |b ill. 
310 |a Six no. a year,  |b 1999- 
321 |a Quarterly,  |b 1985-1990 
321 |a Bimonthly,  |b 1991-1994 
321 |a Eight no. a year,  |b 1995-1998 
362 0 |a Vol. 1, no. 1 (Oct. 1985)- 
362 1 |a Ceased with Vol. 16, 2001. 
500 |a Imprint varies. 
510 1 |9 2  |a Index medicus  |x 0019-3879  |b v1n1, 1985-v16, 2001 
510 1 |9 2  |a MEDLINE  |b v1n1, 1985-v16, 2001 
510 1 |9 2  |a PubMed  |b v1n1, 1985-v16, 2001 
530 |a Some issues are also available online. 
550 |a Publication is made possible by the support of the Cancer Research Campaign. 
583 |3 Vol. 1, no. 1 (OCT 1985)  |c 19911012  |f Notice not published  |l Printed on acid-free paper 
650 2 |a Antineoplastic Agents  |v Periodicals. 
710 2 |a Cancer Research Campaign (Great Britain) 
785 0 4 |t Oncology research  |g 2002  |x 0965-0407  |w (OCoLC)24773354 
856 4 |u http://www.ingentaconnect.com/content/cog/antcan 
910 |a AC5 
999 |c 68776  |d 68776 
952 |0 0  |1 0  |4 0  |7 0  |9 811540  |a M-BNCS  |b M-BNCS  |h 1991-2001.  |o M-BNCS-811540JNL-0266-9536  |p M-BNCS-811540JNL-68776  |t 1114195  |y JNL